InfinityQS listed in 2016 market guide for supply chain visibility software
The company provides end-to...
InfinityQS has been announced as a representative vendor in Gartner's Market Guide for Supply Chain Visibility report.
The company provides end-to-end visibility of manufacturing operations and is a global authority on the subject, maintaining a heavy focus on continuous improvement, allowing it a competitive edge.
According to the report: “Supply chain leaders can use supply chain visibility (SCV) software to improve the operational and financial performance of complex, global value networks. When supply chain business partners at all tiers of the value network, upstream and downstream, can sense and respond to changes in a timely manner, they are better equipped to collaborate on shared goals of improving operational efficiency, reducing risk, or profitably responding to supply chain opportunities and disruptions.”
In today’s competitive manufacturing industry, with production facilities and supply chains becoming more complex, manufacturers and their global supply chain partners are turning to technology for business differentiation. InfinityQS provides enterprise-wide visibility – from suppliers to consumers – through data collection and analysis. Centralised, this data generates real-time and aggregate manufacturing intelligence and business insight to streamline and transform global manufacturing operations.
Michael Lyle, President and CEO of InfinityQS, said: “True quality no longer comes from simply monitoring manufacturing processes on the plant floor. With growing and diverse supply chains, manufacturers need to view enterprise-wide performance in order to understand where improvements can be made across the entire value chain. This makes suppliers, vendors, and other partners an extension of the enterprise. Sharing this responsibility encourages suppliers and manufacturers to collaborate on ways to ensure consumers receive high-quality, safe products that generate the greatest margins for every organisation involved.”
Follow @ManufacturingGL and @NellWalkerMG
IMF: Variants Can Still Hurt Manufacturing Recovery
After a year of on-and-off manufacturing in the US, UK, and the eurozone, demand for goods surged early last week. Factories set growth records in April and May, suppliers started to recover, and US crude hit its highest price point since pre-COVID. As vaccination efforts immunise much of the US and UK populations, manufacturers are now able to fully ramp up their supply chains. In fact, GDP growth could approach double-digits by 2022.
Now, the ISM productivity measure has surpassed the 50-point mark that separates industry expansion from contraction. Since U.S. president Biden passed his US$1.9tn stimulus package and the UK purchasing managers index (PMI) increased to 65.6, both sides of the Atlantic are facing a much-welcomed manufacturing recovery.
Lingering Concerns Over COVID
Even as Spain, France, Italy, and Germany race to catch up, and mining companies pushed the FTSE 100 index of list shares to a monthly high of 7,129, some say that UK and US markets still suffer from a lack of confidence in raw material supplies. Yes, the Dow Jones has made up its 19,173-point crash of March 2020, and MSCI’s global stock index is at an all-time high.
Yet manufacturers around the world realise that these wins will be short-lived until pandemic supply chain bottlenecks are solved. If we keep the status quo, consumers will pay the price. In April, inflation in Germany reached 2.4%, and across the EU’s 19 member countries, overall prices have increased at an unusual pace. Some ask: Is this true recovery?
IMF: Current Boom Could Falter
Even as Elon Musk tweeted about chip shortages forcing Tesla to raise its prices, UK mining demand skyrocketed; housing markets lifted; and the pound sterling gained value. The International Monetary Fund (IMF), however, cautioned that manufacturing recovery won’t last long if COVID mutates into forms our vaccinations can’t touch. Kristalina Georgieva, Washington’s IMF director, noted that fewer than 1% of African citizens have been vaccinated: “Worldwide access to vaccines offers the best hope for stopping the coronavirus pandemic, saving lives, and securing a broad-based economic recovery”.
Across the globe, manufacturing companies are keeping a watchful eye on new developments in the spread of COVID. Though US FDA officials don’t think we’ll have to “start at square one” with new vaccines, the March 2021 World Economic Outlook states that “high uncertainty” surrounds the projected 6% global growth. Continued manufacturing success will in large part depend on “the path of the pandemic, the effectiveness of policy support, and the evolution of financial conditions”.
Mathias Cormann, secretary-general of the Organisation for Economic Co-Operation and Development (OECD) concurred—without global immunisation, the estimated economic boom expected by 2025 could go kaput. “We need to...pursue an all-out effort to reach the entire world population”, Australia’s finance minister added. US$50bn to end COVID across the world, they imply, is a small investment to restart our economies.